312 related articles for article (PubMed ID: 14646676)
1. Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model.
Salu KJ; Huang Y; Bosmans JM; Liu X; Li S; Wang L; Verbeken E; Bult H; Vrints CJ; De Scheerder IK
Coron Artery Dis; 2003 Dec; 14(8):545-55. PubMed ID: 14646676
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
[TBL] [Abstract][Full Text] [Related]
3. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
4. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.
Huang Y; Salu K; Liu X; Li S; Wang L; Verbeken E; Bosmans J; De Scheerder I
Heart; 2004 Feb; 90(2):195-9. PubMed ID: 14729797
[TBL] [Abstract][Full Text] [Related]
6. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
Kipshidze NN; Iversen P; Kim HS; Yiazdi H; Dangas G; Seaborn R; New G; Tio F; Waksman R; Mehran R; Tsapenko M; Stone GW; Roubin GS; Iyer S; Leon MB; Moses JW
Catheter Cardiovasc Interv; 2004 Apr; 61(4):518-27. PubMed ID: 15065150
[TBL] [Abstract][Full Text] [Related]
7. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
8. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
9. Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
Berg R; Aragon J; Royter V; Shanley JF; Cogert G; Vermani R; Kar S; Eigler N; Litvack F
Catheter Cardiovasc Interv; 2007 Nov; 70(6):871-9. PubMed ID: 17932889
[TBL] [Abstract][Full Text] [Related]
10. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model.
De Scheerder I; Szilard M; Yanming H; Ping XB; Verbeken E; Neerinck D; Demeyere E; Coppens W; Van de Werf F
J Invasive Cardiol; 2000 Aug; 12(8):389-94. PubMed ID: 10953100
[TBL] [Abstract][Full Text] [Related]
12. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
[TBL] [Abstract][Full Text] [Related]
14. Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents.
Huang Y; Wang L; Verweire I; Qiang B; Liu X; Verbeken E; Schacht E; De Scheerder I
J Invasive Cardiol; 2002 Sep; 14(9):505-13. PubMed ID: 12205348
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
Heldman AW; Cheng L; Jenkins GM; Heller PF; Kim DW; Ware M; Nater C; Hruban RH; Rezai B; Abella BS; Bunge KE; Kinsella JL; Sollott SJ; Lakatta EG; Brinker JA; Hunter WL; Froehlich JP
Circulation; 2001 May; 103(18):2289-95. PubMed ID: 11342479
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic response after hydrophilic polyethylene glycol-coating stent and hydrophobic octadecylthiol-coating stent implantations in porcine coronary restenosis model.
J Mater Sci Mater Med; ; . PubMed ID: 33247775
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
